Vaxcyte, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.31B +369.3% €13.20M -102.2% 1.0% +2.2 pp N/A N/A
    (estimated) €279.50M +465.4% -€613.03M -19.2% -219.3% +13 pp N/A N/A
    (estimated) €49.44M +244.2% -€758.56M -∞% -1,534.4% -15 pp N/A N/A
    (estimated) €14.36M +∞% N/A N/A N/A N/A
    (estimated) €0.00 +NaN% N/A N/A N/A N/A
    €0.00 +NaN% -€399.70M +15.3% N/A -€370.64M +87.9% N/A
    €0.00 +NaN% -€346.57M +67.9% N/A -€197.22M +38.9% N/A
    €0.00 +NaN% -€206.46M +139.4% N/A -€141.94M +43.5% N/A
    €0.00 +NaN% -€86.23M +14.0% N/A -€98.94M +152.5% N/A
    €0.00 +NaN% -€75.66M +64.2% N/A -€39.18M -1.0% N/A
    €0.00 +NaN% -€46.09M +81.4% N/A -€39.59M +60.1% N/A
    €0.00 +NaN% -€25.40M +71.0% N/A -€24.72M +208,705.8% N/A
    €0.00 -€14.85M N/A -€11.84K N/A

    Notifications